Skip to content

Clinical trials

Recruiting Lung Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Recruiting Country / region: Netherlands Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20171
20181
20191
20211
20223
20237
20247
202512
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Medical Center Groningen5
Bristol-Myers Squibb3
Revolution Medicines, Inc.3
The Netherlands Cancer Institute2
Academisch Ziekenhuis Maastricht1
Amgen1
Amsterdam UMC, location VUmc1
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)1
BioNTech SE1
Catharina Ziekenhuis Eindhoven1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms37
Carcinoma, Non-Small-Cell Lung23
Neoplasms8
Lung Diseases5
Urinary Bladder Neoplasms5
Breast Neoplasms4
Bronchial Neoplasms4
Carcinoma4
Esophageal Neoplasms4
Head and Neck Neoplasms4

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.